UW器官保存液在胰腺移植中的研究进展

近年来,糖尿病发病率在全球呈快速增长的趋势,我国患病率已达到3%.多数Ⅰ型和部分Ⅱ型糖尿病患者需要采用外源性胰岛素注射控制血糖,患者不但要承受胰岛素注射带来的痛苦,而且还不可避免地要发生远期的并发症.因此,重建内源性胰岛分泌系统是近年来人们关注的热点.大量实验表明,胰腺移植不但可以中止胰岛素依赖性糖尿病并发症的发展,还可以转归已有的并发症,明显改善患者的预后.与其他器官移植一样,移植器官的获取及保存是移植成功的前提,由于胰腺组织的特殊性,不同的器官保存液对于保存胰腺效果不一.本文将对University of Wisconsin(UW)保存液在胰腺移植中作用作一论述.

Development of University of Wisconsin (UW) solution in pancreatic transplantation

The incidence of diabetes has a rapid increase trend trend in the whole world. In China, the incidence has come to 3%. The most of patients with type Ⅰ and part of type Ⅱ diabetes rely on exogenious insulin to control blood glucose;they not only have to bear the uncomfortbleness of insulin injection, but also inevitably to face the forward complications, so,the main concern in recent years is to rebuild the endogenous insulin secretion system. Many experiments show that pancreas transplantation not only can stop the development of insulin dependent diabe-tes, but also revert the already existing complications, just like with other organ transplants, the organ access and preservation is prerequisite for success. Because of the specificity of pancreas tissue, the effects of different organ preservation solution for the preservation of the pancreas varies. In this paper we will talk about the effect of UW preservation solution in the pancreas transplantation.